The Korean Journal of Critical Care Medicine  2014;29(1):13-18

doi:10.4266/kjccm.2014.29.1.13

Clinical Characteristics of the Development of Pneumothorax in Mechanically Ventilated Patients in Intensive Care Units.

Wan Chul KIM 1 ; Su Jin LIM ; Kyong Young KIM ; Seung Jun LEE ; Yu Ji CHO ; Yi Yeong JEONG ; Mi Jung PARK ; Kyoung Nyeo JEON ; Jong Deog LEE ; Young Sil HWANG ; Ho Cheol KIM

Affiliations

+expand

Keywords

intensive care unit; mechanical ventilation; pneumothorax

Country

Republic of Korea

Language

English

MeSH

Abstract

BACKGROUND: Pneumothorax (PTX) can occur as a complication of positive pressure ventilation in mechanically ventilated patients. METHODS: We retrospectively reviewed the clinical characteristics of patients who developed PTX during mechanical ventilation (MV) in the intensive care unit (ICU). RESULTS: Of the 326 patients admitted (208 men and 118 women; mean age, 65.3 +/- 8.74 years), 15 (4.7%) developed PTX, which was MV-associated in 11 (3.3%) cases (6 men and 5 women; mean age, 68.3 +/- 9.12 years) and procedure-associated in 4. Among the patients with MV-associated PTX, the underlying lung diseases were acute respiratory distress syndrome in 7 patients, interstitial lung disease in 2 patients, and chronic obstructive pulmonary disease in 2 patients. PTX diagnosis was achieved by chest radiography alone in 9 patients and chest computed tomography alone in 2 patients. Nine patients were using assist-control mode MV with the mean applied positive end-expiratory pressure, 9 +/- 4.6 cmH2O and the mean tidal volume, 361 +/- 63.7 ml at the diagnosis of PTX. Two patients died as a result of MV-associated PTX and their systolic pressure was below 80 mmHg and heart rates were less than 80/min. Ten patients were treated by chest tube insertion, and 1 patient was treated by percutaneous pigtail catheter insertion. CONCLUSIONS: PTX can develop in patients undergoing MV, and may cause death. Early recognition and treatment are necessary to prevent hemodynamic compromise in patients who develop PTX.